Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Investors

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

Minimum 15 minutes delayed. Source: LSEG

Show all

Latest Results | Q2 2026

  • Earnings Release

Events

29 Jun 2026 5:00 PM EDT
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
03 Jun 2026 11:40 AM EDT
Jefferies Global Healthcare Conference
02 Jun 2026 9:00 AM EDT
William Blair 46th Annual Growth Stock Conference
30 Apr 2026 9:30 AM AEST
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
17 Mar 2026 3:00 PM EDT
HCW @ Home with Telix Pharmaceuticals
  • All Events

 

Presentations

Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
  • All Presentations

News

24 Jul 2026
Change in substantial holding
21 Jul 2026
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal
21 Jul 2026
Q2 2026 Revenue US$247M Strong Momentum Pipeline Progress
20 Jul 2026
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer
15 Jul 2026
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
  • All News Releases

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors